{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:52:43Z","timestamp":1781560363072,"version":"3.54.5"},"reference-count":56,"publisher":"American College of Physicians","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.7326\/annals-25-05154","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:00:37Z","timestamp":1776718837000},"page":"839-841","source":"Crossref","is-referenced-by-count":0,"title":["Reforming 340B to Promote Program Integrity and Better Serve Vulnerable Populations: An American College of Physicians Policy Brief"],"prefix":"10.7326","volume":"179","author":[{"given":"Josh","family":"Serchen","sequence":"first","affiliation":[{"name":"American College of Physicians, Washington, DC (J.S.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah W.","family":"Beachy","sequence":"additional","affiliation":[{"name":"University of Nebraska Medical Center, Omaha, Nebraska (M.W.B.)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla W.","family":"Carr","sequence":"additional","affiliation":[{"name":"Central Vermont Medical Center, Barre, Vermont (P.W.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Health and Public Policy Committee of the American College of Physicians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah W.","family":"Beachy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla W.","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesleigh A.","family":"Box","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Jumper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Leser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy L.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvam Joseph","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Oslock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny R.","family":"Silberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamar","family":"Slocum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4285","reference":[{"key":"r1-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.7326\/M15-2768"},{"key":"r2-ANNALS2505154","unstructured":"Bosworth A, Sheingold S, Finegold K, et al\n                      . Changes in the list prices of prescription drugs, 2017-2023. U.S. Department of Health and Human Services; 2023. Accessed at https:\/\/collections.nlm.nih.gov\/catalog\/nlm:nlmuid-9918751185806676-pdf on 3 October 2025."},{"key":"r3-ANNALS2505154","first-page":"5","volume":"11","author":"Mulcahy AW","year":"2024","journal-title":"Rand Health Q"},{"key":"r4-ANNALS2505154","unstructured":"Sparks G, Kirzinger A, Montero A, et al\n                      . Public opinion on prescription drugs and their prices. KFF; 2024. Accessed at www.kff.org\/health-costs\/public-opinion-on-prescription-drugs-and-their-prices\/ on 3 October 2025."},{"key":"r5-ANNALS2505154","unstructured":"Rogers H-A\n                      . Overview of the 340B Drug Discount Program. Congressional Research Service; 2022. Accessed at www.congress.gov\/crs-product\/IF12232 on 3 October 2025."},{"key":"r6-ANNALS2505154","unstructured":"340B Drug Discount Program: oversight of the intersection with the Medicaid Drug Rebate Program needs improvement. U.S. Government Accountability Office; 2020. Accessed at www.gao.gov\/products\/gao-20-212 on 3 October 2025."},{"key":"r7-ANNALS2505154","unstructured":"Gu CA, Rodenmeyer K, Shirley TM, et al\n                      . Protecting federally qualified health centers amid drugstore closures and threats to 340B. Health Affairs Forefront. 15 July 2024. Accessed at www.healthaffairs.org\/do\/10.1377\/forefront.20240712.411482\/full\/ on 3 October 2025."},{"key":"#cr-split#-r8-ANNALS2505154.1","unstructured":"HR Rep No. 102-384, pt. 2, at 12 (1992) (discussing bill to amend the Social Security Act)"},{"key":"#cr-split#-r8-ANNALS2505154.2","unstructured":"see also Veterans Health Care Act of 1992, Pub L No. 102-585, \u00a7602(a), 106 Stat 4943, 4967 (adding section 340B to the PHSA)."},{"key":"r9-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxaf104"},{"key":"r10-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0540"},{"key":"r11-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12691"},{"key":"r12-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.7326\/M19-2411"},{"key":"r13-ANNALS2505154","unstructured":"340B Eligibility. Health Resources and Services Administration; 2024. Accessed at www.hrsa.gov\/opa\/eligibility-and-registration on 3 October 2025."},{"key":"r14-ANNALS2505154","unstructured":"2023 340B Covered entity purchases. Health Resources and Services Administration; 2024. Accessed at www.hrsa.gov\/opa\/updates\/2023-340b-covered-entity-purchases on 3 October 2025."},{"key":"r15-ANNALS2505154","unstructured":"Program requirements. Health Resources and Services Administration; 2024. Accessed at www.hrsa.gov\/opa\/program-requirements on 3 October 2025."},{"key":"r16-ANNALS2505154","unstructured":"Notice Regarding Section 602 of the Veterans Health Care Act of 1992 Patient and Entity Eligibility. Fed Regist. 1996;61:55156-55158. Accessed at www.govinfo.gov\/content\/pkg\/FR-1996-10-24\/pdf\/96-27344.pdf on 3 October 2025."},{"key":"r17-ANNALS2505154","unstructured":"Congress must act to bring needed reforms to the 340B Drug Pricing Program. U.S. Senate Committee on Health, Education, Labor, and Pensions; 2025. Accessed at www.help.senate.gov\/imo\/media\/doc\/final_340b_majority_staff_reportpdf.pdf on 3 October 2025."},{"key":"r18-ANNALS2505154","unstructured":"Fein AJ\n                      . Exclusive: for 2023, five for-profit retailers and PBMs dominate an evolving 340B contract pharmacy market. Drug Channels. 11 July 2023. Accessed at www.drugchannels.net\/2023\/07\/exclusive-for-2023-five-for-profit.html on 3 October 2025."},{"key":"r19-ANNALS2505154","unstructured":"National Association of Community Health Centers.\n                      340B: A critical program for health centers. 13 June 2022. Accessed at www.nachc.org\/wp-content\/uploads\/2022\/06\/NACHC-340B-Health-Center-Report_-June-2022-pdf on 18 March 2026."},{"key":"r20-ANNALS2505154","unstructured":"Drug discount program: characteristics of hospitals participating and not participating in the 340B Program. U.S. Government Accountability Office; 2018. Accessed at www.gao.gov\/products\/gao-18-521r on 3 October 2025."},{"key":"r21-ANNALS2505154","unstructured":"Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement. U.S. Government Accountability Office; 2018. Accessed at www.gao.gov\/products\/gao-18-480 on 3 October 2025."},{"key":"r22-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.3716"},{"key":"r23-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-021-05642-4"},{"key":"r24-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1435"},{"key":"r25-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2021.88761"},{"key":"r26-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13278"},{"key":"r27-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.2015"},{"key":"r28-ANNALS2505154","unstructured":"Gustafson K, Isaiah E, Morley M, et al\n                      . 340B Hospital child sites and contract pharmacy demographics. Avalere Health; 2022. Accessed at https:\/\/advisory.avalerehealth.com\/insights\/340b-hospital-child-sites-and-contract-pharmacy-demographics on 3 October 2025."},{"key":"r29-ANNALS2505154","unstructured":"Waxman HA\n                      . 30 Years of 340B: preserving the health care safety net. Health Affairs Forefront. 7 December 2022. Accessed at www.healthaffairs.org\/do\/10.1377\/forefront.20221205.854706\/full\/ on 3 October 2025."},{"key":"r30-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.0833"},{"key":"r31-ANNALS2505154","unstructured":"Hammond J\n                      . Primer: the 340B Drug Pricing Program - challenges and solutions. American Action Forum; 2022. Accessed at www.americanactionforum.org\/research\/the-340b-drug-pricing-program-challenges-and-solutions\/ on 3 October 2025."},{"key":"r32-ANNALS2505154","unstructured":"Wofford D\n                      . Your guide to legislation on the 340B Drug Pricing Program. Third Way; 2025. Accessed at www.thirdway.org\/memo\/your-guide-to-legislation-on-the-340b-drug-pricing-program on 3 October 2025."},{"key":"r33-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.1356"},{"key":"r34-ANNALS2505154","unstructured":"DiGiorgio AM.\n                      340B: Good intentions in need of reform. Health Affairs Forefront. 1 February 2023. Accessed at www.healthaffairs.org\/do\/10.1377\/forefront.20230130.261869\/full\/ on 3 October 2025."},{"key":"r35-ANNALS2505154","unstructured":"Wofford D, Kendall D\n                      . Fixing a critical safety net program: 340B. Third Way; 2023. Accessed at www.thirdway.org\/report\/fixing-a-critical-safety-net-program-340b on 3 October 2025."},{"key":"r36-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.7326\/M21-1178"},{"key":"r37-ANNALS2505154","unstructured":"Turnipseed DP\n                      . Letter to Sens. Thune, Stabenow, Capito, Baldwin, Moran, and Cardin. 1 April 2024. Accessed at www.aamc.org\/media\/75521\/download?attachment on 3 October 2025."},{"key":"r38-ANNALS2505154","unstructured":"Growth in the 340B Drug Pricing Program. Congressional Budget Office; 2025. Accessed at www.cbo.gov\/system\/files\/2025-09\/60661-340B-program.pdf on 3 October 2025."},{"key":"r39-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0833"},{"key":"r40-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2022.88840"},{"key":"r41-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxad075"},{"key":"r42-ANNALS2505154","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxad052"},{"key":"r43-ANNALS2505154","unstructured":"340B Restrictions summary chart. National Association of Community Health Centers; 2023. Accessed at www.nachc.org\/wp-content\/uploads\/2023\/09\/340B-restrictions-summary-chart.pdf on 3 October 2025."},{"key":"r44-ANNALS2505154","unstructured":"Rogers H-A\n                      . Litigation continues over use of contract pharmacies in 340B Drug Discount Program. Congressional Research Service; 2024. Accessed at www.congress.gov\/crs-product\/LSB11163 on 3 October 2025."},{"key":"r45-ANNALS2505154","unstructured":"Ingmire B\n                      . The evolving landscape of 340B drug pricing laws. MultiState; 2025. Accessed at www.multistate.us\/insider\/2025\/5\/1\/the-evolving-landscape-of-340b-drug-pricing-laws on 3 October 2025."},{"key":"r46-ANNALS2505154","unstructured":"State-level 340B laws and legislation tracker. National Association of Community Health Centers; 2025. Accessed at www.nachc.org\/resource\/state-level-340b-laws-and-legislation-tracker\/ on 3 October 2025."},{"key":"r47-ANNALS2505154","unstructured":"340B Drug Discount Program: increased oversight needed to ensure nongovernmental hospitals meet eligibility requirements. U.S. Government Accountability Office; 2019. Accessed at www.gao.gov\/products\/gao-20-108 on 3 October 2025."},{"key":"r48-ANNALS2505154","unstructured":"Scott M, Keene C, Flint A, et al\n                      . 340B Stakeholders consider impacts of duplicate discounts. Avalere Health Advisory; 2023. Accessed at https:\/\/advisory.avalerehealth.com\/insights\/340b-stakeholders-consider-impacts-of-duplicate-discounts on 13 November 2025."},{"key":"r49-ANNALS2505154","unstructured":"Greenwalt L\n                      . Trends to watch through 2023: the 340B Drug Discount Program. IQVIA; 2022. Accessed at www.iqvia.com\/locations\/united-states\/blogs\/2022\/03\/trends-340b-drug-discount-program on 3 October 2025."},{"key":"r50-ANNALS2505154","unstructured":"McCaughan M\n                      . The 340B Drug Discount Program. Project HOPE; 2017. Accessed at www.healthaffairs.org\/do\/10.1377\/hpb20171024.663441\/full\/ on 3 October 2025."},{"key":"r51-ANNALS2505154","unstructured":"Program integrity: FY24 audit results. Health Resources and Services Administration; 2025. Accessed at www.hrsa.gov\/opa\/program-integrity\/fy-24-audit-results on 3 October 2025."},{"key":"r52-ANNALS2505154","unstructured":"Examining HRSA\u2019s oversight of the 340B Drug Pricing Program. U.S. Government Publishing Office; 2017. Accessed at www.govinfo.gov\/content\/pkg\/CHRG-115hhrg26929\/html\/CHRG-115hhrg26929.htm on 3 October 2025."},{"key":"r53-ANNALS2505154","unstructured":"Badger E, Paris F, Parlapiano A\n                      . 220,000 Fewer workers: how Trump\u2019s cuts affected every federal agency. The New York Times. 9 January 2026. Accessed at www.nytimes.com\/interactive\/2026\/01\/09\/upshot\/trump-workforce-cuts-table.html on 6 February 2026."},{"key":"r54-ANNALS2505154","unstructured":"Martin K\n                      . The 340B Drug Pricing Program: how it works and why it\u2019s controversial. The Commonwealth Fund; 2025. Accessed at www.commonwealthfund.org\/publications\/explainer\/2025\/aug\/340b-drug-pricing-program-how-it-works-and-why-its-controversial on 3 October 2025."},{"key":"r55-ANNALS2505154","unstructured":"Early B\n                      . 340B May move from HRSA to CMS: what you need to know. Modern Healthcare. 2 June 2025. Accessed at www.modernhealthcare.com\/policy\/340b-drug-program-hrsa-cms\/ on 3 October 2025."}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-25-05154","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-25-05154","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:02:45Z","timestamp":1781557365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-25-05154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.7326\/ANNALS-25-05154"],"URL":"https:\/\/doi.org\/10.7326\/annals-25-05154","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}